a

aVaxziPen

21 employees

aVaxziPen is focusing on next-generation vaccines for infectious diseases and emerging threat pathogens.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Life Science

Date founded

2017

Funding rounds raised

Total raised

$1.6M

from 1 investors over 1 rounds

a

aVaxziPen raised $1.6M on June 6, 2023

Investors: CEPI (Coalition for Epidemic Preparedness Innovations)

FAQ